Express Pharma (May 15-31, 2017) EXPANDING ACCESS Express Pharma has always taken a keen interest in India’s progress in the public welfare. Ascertaining that commitment to public health, this...
Deal value decreases to $7.1 billion when compared five months average of $10.6 billion
Increased market diversification is expected due to patent expiries for major insulin products
The drug is already approved for patients who have been treated with Pfizer's lung cancer drug Xalkori
The burden of diagnosed Crohn’s Disease (CD) is expected to grow between 2016 and 2026 in the seven major markets
The company anticipates a steady stream of novel therapies to enter the OA marketplace over the next 10 years
Trends indicate that medical tourism will also bolster the demand for sophisticated devices
The immunotherapy Kymriah is a key element of Novartis’s efforts to bolster its portfolio of oncology drugs
The decision by the Food and Drug Administration paves the way for a speedy regulatory review of the BCMA drug for multiple myeloma
Certain bacteria seem to help in cancer by priming immune cells and smoothing the path for immunotherapy drugs known as PD-1 drugs
The drug is expected to be available from December, was approved both as a tablet and an injection
The trials shows the efficacy and safety of biosimilar adalimumab
The Basel-based drugmaker hopes this latest analysis lends RTH258 additional muscle when matched head-to-head with Eylea
J&J said the results were strong enough to advance Stelara into larger Phase III testing
Suresh Pareek, MD, Ideal Cures, in an interaction with Express Pharma, talks about the uniqueness of INSTACOAT 4G, which was recently displayed at CPhI Worldwide
Risk-based monitoring (RBM) adoption is building momentum as pharma companies and CROs are shifting focus and are developing strategies to develop processes. An insight by Dr Bina Naik, Chief...
Daniel Zakowiecki, Marek Lachmann and Tobias Heß Chemische Fabrik Budenheim, in this article outlines the most important properties of various grades of calcium salts of orthophosphoric acid
The patients, all of whom had an occlusion of the intracranial internal carotid or proximal middle cerebral artery, were treated at 26 centres in the...
The vaccine developed by Bharat Biotech could also be used safely in babies
Suresh Pareek, MD, Ideal Cures and Sanjay Negi, DGM Film Coatings, Ideal Cures, give an insight the coating performance of IDEAL CURES revolutionary product INSTACOAT 4G with high solids...
Dr Michael Caves, India Business Development Manager, Malvern Instruments, in an interaction with Express Pharma, talks about the benefits of XRPD systems and its usage for multiple applications
Suresh Pareek, MD, Ideal Cures and Sanjay Negi, DGM Film Coatings, Ideal Cures, evaluates coating uniformity and appearance of tablets coated with Ideal Cures’ revolutionary product INSTACOAT 4G, a...
Hiroshi Watanabe, GM, Shin-Etsu Chemical Company, Japan, Shungo Fujii, Sales Manager, Shin-Etsu Chemical Company, Japan and Nitin Bhusane, Director, Shin-Etsu Chemcial Tylose India, in an interaction with Express Pharma,...
KOLKATA-BASED NEOMACHINE MFG CO was started in 1973 with an objective of manufacturing quality pharmaceutical machinery
Mitul Shah, CEO, LabGuard India, in an interaction with Express Pharma talks about LabGuard’s future growth prospects
Aditya Marfatia, Director, Electrolab and Dr Neelam Sayed, Application Scientist, Electrolab give an insight about how Electrolab with a technological collaboration has introduced a convenient 21 CFR part 11...
Dr Kiran Badgujar, Founder and Director, Mack Pharmatech, talks about Mack Pharmatech’s services to the pharma industry and its growth prospects in an interaction with Express Pharma